Nektar Therapeutics (NKTR) Tax Provisions (2010 - 2026)
Nektar Therapeutics (NKTR) posted quarterly Tax Provisions of $64000.0 for Q1 2026, up 23.08% year-over-year from $52000.0 in Q1 2025, and up 100.19% quarter-over-quarter from -$34.3 million in Q4 2025.
Nektar Therapeutics (NKTR) Tax Provisions (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Tax Provisions history runs 17 years deep, the most recent figure standing at $64000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 23.08% year-over-year to $64000.0; the TTM figure through Mar 2026 stood at -$34.5 million (down 38.2% YoY), while the FY2025 annual figure was -$34.5 million, down 37.76% from the prior year.
- Tax Provisions for Q1 2026 stood at $64000.0, up from -$34.3 million in the prior quarter.
- The five-year high for Tax Provisions was $126000.0 in Q1 2022, with the low at -$76.7 million in Q4 2022.
- The 5-year median for Tax Provisions is -$35000.0 (2024), against an average of -$8.0 million.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions plunged 1917850.0% in 2022, then soared 248.57% in 2025.
- Nektar Therapeutics' Tax Provisions stood at -$76.7 million in 2022, then soared by 99.96% to -$29000.0 in 2023, then sank by 86286.21% to -$25.1 million in 2024, then sank by 36.98% to -$34.3 million in 2025, then jumped by 100.19% to $64000.0 in 2026.
- Business Quant data shows NKTR's Tax Provisions at $64000.0 in Q1 2026, -$34.3 million in Q4 2025, and -$33000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn | 64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,000.00 |
| Dec 31, 2025 | -34.32 Mn |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -188,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | -25.05 Mn |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Sep 30, 2023 | -61,000.00 |
| Jun 30, 2023 | -47,000.00 |
| Mar 31, 2023 | -63,000.00 |
| Dec 31, 2022 | -76.72 Mn |
| Sep 30, 2022 | -155,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 126,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | 112,000.00 |
| Jun 30, 2021 | 357,000.00 |